Statistics for Inhibrx, (id:6483 INBX)

Valuation metrics

Market cap

202.37M

Enterprise value

-17,249,296.00

Trailing P/E (ttm)

0.12

Forward P/E

-1.27

PEG ratio

-1.27

Price/Sales (ttm)

119.96

Price/Book (mrq)

0.92

Enterprise Value/Revenue

-10.22

Enterprise Value/EBITDA

0.06

Overview

Shares outstanding

14.48M

Float

7.68M

Shares short

895.66K

% Held by insiders

0.24%

% Held by institutions

0.67%

Average volume (10 days)

97.99K

Average volume (90 days)

Price summary

52-Week low

10.80

52-Week high

39.79

52-Week change

-45.88%

Beta

50-Day moving average

15.68

200-Day moving average

14.74

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

101.97K%

Operating margin

-160,898.00%

Operational effectiveness

Return on assets

-596.02%

Return on equity

1.94K%

Income statement

Revenue (ttm)

0.12

Revenue per share (ttm)

0.12

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-300,927,008.00

Net income to common (ttm)

1.72B

Diluted EPS (ttm)

119.39

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

226.86M

Total cash per share (mrq)

15.67

Total debt (mrq)

2.17M

Total Debt/Equity (mrq)

0.99

Current ratio (mrq)

619.80%

Book value per share (mrq)

15.15

Cash flow

Cash flow statement

-167,172,000.00

Levered free cash flow (LFCF)

-154,964,000.00